Fractional shares
Get dividend payments
A subsidiary of Johnson & Johnson, Janssen is a Belgian pharmaceutical company which announced in January 2021 that its single-dose COVID-19 vaccine is 66% effective. As a single-dose jab, the vaccine would be easier to roll out than existing vaccines, and could help boost the international vaccination effort. While the vaccine has yet to be approved by regulators, the UK has already pre-ordered 30 million doses.
Janssen Pharmaceuticals is a pharmaceutical company that researches medical disorders, such as mental illness, neurological disorders and gastrointestinal disorders, for the development of new drugs. Janssen is one of the companies that has created a vaccine for COVID-19, having received $456 million (£342 million) from the U.S. Biomedical Advanced Research and Development Authority.
It’s possible to invest in Janssen Pharmaceuticals, but as it’s owned by Johnson & Johnson, you’d need to buy Johnson & Johnson shares.
This means that if you choose to invest in Janssen by buying shares in Johnson & Johnson, then you’ll be investing in the other brands that it owns as well. Research all of the brands above and other brands that Johnson & Johnson owns to get a full picture of the company.
Open | $161.36 | Previous close | $160.65 |
High | $161.39 | Change | $-0.24 |
Low | $160.03 | Change % | -0.1494% |
Close | $160.41 | Timestamp | 2024-10-10 |
Volume | 1445431 | GMT offset | 0 |
Industry | Drug Manufacturers - General | Currency symbol | $ |
Code | JNJ | Country name | USA |
Type | Common Stock | Country ISO | US |
Name | Johnson & Johnson | ISIN | US4781601046 |
Exchange | NYSE | CUSIP | 478160104 |
Currency code | USD | Sector | Healthcare |
Currency name | US Dollar | Full-time employees | 131900 |
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Janssen was founded in 1953 and has produced a huge range of drugs, including 8 that are included in the World Health Organisation’s Model List of Essential Medicines. It’s one of the companies that’s created a vaccine against coronavirus, which has been approved in several countries, including the UK.
Johnson & Johnson owns some of the most recognisable brands in the healthcare aisle in the supermarket. If you’re umming and ahhing between two facial washes, there’s a pretty good chance they’re both made by Johnson & Johnson.
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.
Ever wondered how to buy shares in Green Thumb Industries? We explain how and compare a range of providers that can give you access to many brands, including Green Thumb Industries.
Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.
Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.
Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.
Ever wondered how to buy shares in 4D pharma? We explain how and compare a range of providers that can give you access to many brands, including 4D pharma.
Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.
Thinking about buying shares in Evgen Pharma? We explain how to do it and compare a range of providers who will give you access to global markets.
Ever wondered how to buy shares in Intuitive Surgical? We explain how and compare a range of providers that can give you access to many brands, including Intuitive Surgical.
Ever wondered how to buy shares in Stryker? We explain how and compare a range of providers that can give you access to many brands, including Stryker.